From: Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma
clinicopathological characteristics | OS (month) | DFS (month) | ||||
---|---|---|---|---|---|---|
mean OS | 95%CI | p-value | mean DFS | 95%CI | p-value | |
FIGO stage | ||||||
I | 86.404 | 81.673–91.134 | 0.002 | 80.687 | 73.876–87.498 | 0.022 |
II | 83.097 | 73.588–92.605 | 79.356 | 68.054–90.659 | ||
III | 58.090 | 47.000–69.181 | 54.750 | 42.077–67.423 | ||
Silva system | ||||||
pattern A | NA | NA | 0.205 | NA | NA | 0.181 |
pattern B | NA | NA | NA | NA | ||
pattern C | NA | NA | NA | NA | ||
DOI | ||||||
<1/2 | 87.784 | 83.232–92.336 | 0.008 | 82.859 | 75.953–89.764 | 0.047 |
>1/2 | 77.488 | 69.949–85.026 | 72.234 | 63.135–81.333 | ||
SCS grade | ||||||
grade I (score 2–3) | NA | NA | 0.014 | 88.348 | 81.347–95.349 | 0.024 |
grade II (score 4–5) | NA | NA | 82.860 | 72.364–93.357 | ||
grade III (score 6–7) | NA | NA | 71.109 | 61.975–80.244 | ||
LVI | ||||||
Negative | 90.817 | 86.852–94.782 | 0.000 | 84.004 | 77.212–90.797 | 0.021 |
Positive | 72.566 | 63.005–82.126 | 69.811 | 59.064–80.558 | ||
LNM | ||||||
Negative | 87.262 | 82.714–91.809 | 0.001 | 81.841 | 75.678–88.004 | 0.007 |
Positive | 58.090 | 47.000–69.181 | 54.750 | 42.077–67.423 |